{"paper_id":"8022ca58-5137-471d-842c-64cf9ad27c93","body_text":"Page 1/14\nLow Expression of STING Promoted Endometrial\nStromal Cells Invasion and Migration Via\nSTING/IRF3/IFNb1 Pathway in Endometriosis\nEutopic Endometrium\nzhen xu \nShandong University\nhen zhao \nShandong University\ncaixin yue \nShandong University\nlixia zhang \nShandong University\nmuzi li \nShandong University\nyuqing wang \nShandong University\nyanbo du \nShandong University\nlei yan  (  yanlei@sdu.edu.cn )\nShandong University School of Medicine: Shandong University Cheeloo College of Medicine\nResearch\nKeywords: endometriosis, innate immunity, eutopic endometrium, invasion, migration\nPosted Date: July 28th, 2021\nDOI: https://doi.org/10.21203/rs.3.rs-709514/v1\nLicense:   This work is licensed under a Creative Commons Attribution 4.0 International License.  \nRead Full License\n\nPage 2/14\nAbstract\nBackground: Recent studies have conrmed that endometriosis is a chronic inammatory disease. In our\nprevious work, we found that STING (stimulator of interferon genes) was differentially expressed in\neutopic endometrium and controlled endometrium by proteomics.\nMethod: we used the 11 pairs of samples to verify STING expression by WB and IHC experiments. We\ndetected cells proliferation by EdU assays, cells invasion and migration by Transwell assays. The effect\nof signaling pathway in HESC was detected by WB and Elisa expreriments.\nResults: STING was signicantly lower expressed in eutopic endometrium of endometriosis, while IHC\nresults showed that STING was expressed in both stroma and glandular epithelium of normal\nendometrium, but in endometriosis, STING was mainly expressed in the stroma of eutopic endometrium,\nand mainly in glandular epithelium of ectopic endometrium. Further study on the role of STING on\nendometrial stromal cells showed that low expression of STING could promote the HESC proliferation by\nEdU experiments, invasion and migration by Transwell experiments. The effect of STING/IRF3/IFNb1\nsignaling pathway in HESC with low expression of STING was also reduced, mainly showed the\ndecreased expression of phosphorylated IRF3 and TBK1, and the decreased secretion of IFNb1. In order\nto further study the effect of IFNb1, secreted by STING/ IRF3/IFNb1 signaling pathway, on stromal cells,\nwe added exogenous IFNb1 to the HESC with low expression of STING, and found that IFNb1 could\nreverse the invasion and migration function of stromal cells, but little effect on cell proliferation.\nConclusions: We claried that STING expressed mainly in stromal tissues and lower in endometriosis\neutopic endometrium compared to normal endometrium. Low expressed STING promoted stromal cells\ninvasion and migration via STING/IRF3/IFNb1 signaling pathway.\nIntroduction\nEndometriosis is gernerally considered as a chronic inammation disease, ectopic lesions of\nendometriosis formed by eutopic endometrium after immune escape, invasion and migration[1]. In\naddition, a meta-analysis showed that there was a correlation between endometriosis and autoimmune\ndiseases[2]. The immune related pathogenic factors of endometriosis are mainly divided into the\nfollowing two parts: the immune dysfunction of endometriosis and the imbalance of immune\nmicroenvironment in ectopic lesions [1, 3–6].\nIn our previous study[7], the endometrial samples were identied by proteomics technology, we found that\nthe differential proteins expression of innate immune proteins in endometriosis accounted for more. After\nfurther analysis, we found that the expression of stimulator of interferon genes (STING) decreased in\neutopic endometrium of endometriosis. STING, also known as TMEM173, as a key DNA receptor adaptor\nprotein, plays an important role in the innate immune signal pathway induced by virus. Cyclic GMP-AMP\nsynthase (cGAS)–STING signal pathway is also a key pathway in the innate immune process[8]. STING\nalso plays different roles in many organ diseases, including lung cancer cells, synovial cells, breast\n\nPage 3/14\ncancer cells and so on[9–12]. One study reported that the expression of STING protein in ectopic\nendometrium with endometriosis was higher than that in eutopic endometrium[13], and the expression of\nSTING protein in glandular epithelium was higher than that in stromal cells. However, this article did not\ncompare the expression of STING protein in eutopic endometrium with endometriosis and normal\nendometrium without endometriosis, also did not explore the mechanism, which indicating that this eld\nstill needs further exploration.\nWe collected eutopic endometrium and ectopic endometrium with endometriosis and eutopic\nendometrium of normal women for immunohistochemical analysis, which based on proteomics research.\nIt was found that STING protein was only expressed in stromal tissue of eutopic endometrium with\nendometriosis, which was lower than that of normal women. Low expression of STING protein promoted\nthe proliferation of endometrial stromal cells invasion and migration function.\nMaterials And Methods\nPatients and sample collection\nFresh endometrial eutopic tissues from 11 patients with endometriosis were collected during the late\nproliferative phase of the menstrual cycle (Day11 ~ 13) and from 11 women of reproductive age who\nunderwent oviduct obstruction as controls. The diagnosis was conrmed by laparoscopy. Samples were\ncollected from October 2018 to December 2019 at the Reproductive Hospital Aliated to Shandong\nUniversity. Women undergoing hysteroscope-laparoscopic surgery for suspected endometriosis were\nconrmed by histological examination, no comorbidities such as PCOS, POI or IBD, so did the controls.\nInformed consent was obtained from patients before surgery. All surgical patients received no hormonal\ntreatments 3 months prior to surgery. Patients data were collected, including age, body mass index, and\nhormone levels. The study was approved by the Institutional Review Board (IRB) of the Reproductive\nHospital Aliated to Shandong University.\nCell culture and transfection assay\nHuman endometrial stromal cells (HESC)were cultured with 90% non-phenol red DMEM/F12 (Gibco)\nsupplemented with 10% FBS and 1% P/S in a 5% CO2 atmosphere at 37°C. si-STING were purchased\nfrom Genepharma (GenePharma, Co., Ltd., Shanghai, China). When HESC reached 70–80% conuence,\ntransfection was conducted with Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) according to the\nmanufacturer’s instructions. Cells were harvested after 48 h for other assays.\nProtein extraction and western blotting\nRadioimmunoprecipitation assay buffer (RIPA, Beyotime, Shanghai, China) was used to lyse cells after\ntransfection for 48 h, followed by the determination of the protein concentration using bicinchoninic acid\n(BCA; Beyotime). The protein was separated by 10% sodium dodecylsulphate-polyacrylamide gel\nelectrophoresis (SDS-PAGE), followed by transfer to a polyvinylidene diuoride (PVDF) membrane\n\nPage 4/14\n(Immobilon-P). After blocking in 5% non-fat milk at room temperature for 1 h, the primary antibody was\nadded and incubated in a refrigerator at 4°C overnight. Tris-buffered saline-Tween (TBST) was used to\nwash the membrane for 15 min 3 times, and the corresponding secondary antibody was added and\nincubated for 1 h at room temperature (about 25 ℃ ). After washing each sample for 15 min 3 times with\nTBST, the protein was detected using the ECL detection system (Millipore, Billerica, MA, USA). Primary\nantibodies against rabbit anti-human STING (1:1000 dilution, CST13647, USA), rabbit anti-human\nTBK1(1:1000 dilution, CST38066, USA), rabbit anti-human p-TBK1(1:1000 dilution, CST5483, USA), rabbit\nanti-human IRF3(1:1000 dilution, CST4302, USA), rabbit anti-human p-IRF3(1:1000 dilution, CST29047,\nUSA), and mouse anti-human Tublin (1:10000 dilution; Proteintech 11224-1-Ig, Rosemont, IL, USA) were\nused. Goat anti-rabbit and Goat anti-mouse HRP-conjugated secondary antibodies were obtained from\nZSGB-BIO (1:10000 dilution, Beijing, China).\n5-Ethyl-2′-Deoxyuridine Incorporation (EdU) assay\nFor the EdU assay, HESC were incubated with 50 µmol/L EdU (RiboBio, Guangzhou, China) for 6 h at 37°C\nand then xed with 4% paraformaldehyde for 30 min at room temperature. After incubation with Apollo\nreaction reagent for 30 min, the cells were stained with Hoechst 33342. The Olympus 1X51 (Tokyo,\nJapan) was used to capture images of HESC, and cells in ve random elds per group were counted. The\nEdU incorporation rate was estimated as the ratio of EdU-positive cells to Hoechst-positive cells.\nTranswell assays\nTranswell assays were performed using 24-well plates with 8-µm pore size inserts (Corning Life Sciences,\nCorning, NY, USA) according to the manufacturer’s protocols. HESC were plated into Transwell chambers\nafter 48 h of transfection. The essential difference between the migration and invasion assays is that, for\nmigration assays cells can migrate through the inserts directly, but for invasion assays they have to\ninvade the matrix to reach the inserts. Details are shown as follows.\nIn the migration assay, the HESC(105cells/well) were seeded into the upper chamber in 200 µL of serum-\nfree phenol red-free DMEM/F12 and allowed to migrate for 24 h to the lower chamber, which contained\nphenol red-free DMEM/F12 with 10% FBS.\nIn the invasion assay, Matrigel (1 mg/mL; BD Biosciences, Franklin Lakes, NJ, USA), prepared in serum-\nfree phenol red-free DMEM/F12 medium, was placed in the upper chamber and incubated for 8 h at 37°C.\nSimilar to the migration assay, HESC (105 cells/well) were seeded in the upper chamber with 200 µL of\nserum-free medium and allowed to invade the lower chamber, which contained medium with 10% FBS, for\n36 h.\nTranswell lters were xed with 4% paraformaldehyde for 30 min, stained with hematoxylin for 30 min,\nand xed on a glass slide. Cells that did not migrate or invade were wiped off with cotton swabs. The\nresults were expressed as the number of cells that migrated or invaded per eld, as counted using the\nOlympus 1X51 microscope in ve random elds.\n\nPage 5/14\nImmunohistochemistry analysis\nFresh tissue samples were washed with PBS several times to remove blood. Then, they were xed in\n4%PFA for 24h and embedded into paran. The samples were cut into 4um sections and mounted onto\nglass slides. Deparanized, rehydrated sections were incubated with 3%H2O2 for 30min to block\nendogenous peroxidase activity. Antigen retrieval was performed using a pressure-cooker for 15min in\nEDTA buffer in boiling water. The sections were rinsed in PBS, blocked with 10% BSA for 30min, and then\nincubated with primary antibodies rabbit anti-human STING (diluted 1:100, CST13647, USA) overnight in\na wet chamber at 4 ℃ . HRP-conjugated goat anti-rabbit or mouse IgG was used as the second antibody.\nHRP activity was detected by measuring the level of the DAB for several seconds. The sections were\ncounterstained with haematoxylin before mounting. The sections were observed under an Olympus 1X51\nmicroscope.\nElisa experiment\nFor the Elisa assay, protocols were based on Human IFN-beta ELISA Kit (R&D 41410-1). Add 50ul sample\ndiluent, 50ul standard in blank microtiter plate, incubated 1h then aspirated and wash 3 times. Add 100ul\ndiluted HRP solution, incubated 1h then as aspirated and wash 3 times. Add 100ul TMB substrate,\nincubated 15min in the dark do not seal or wash. Add 100ul Stop Solution and read plate within 5min at\n450nm.\nStatistical Analysis\nStatistical analyses were performed using SPSS 21.0 (Statistical Package for the Social Sciences, SPSS,\nInc., Chicago, IL, USA). Values were expressed as means ± SD, and comparisons were performed using\nStudent’s t-tests. P < 0.05 was considered statistically signicant. Each experiment was repeated three\ntimes.\nResults\nAnalysis of proteomics results suggested that NF-kB and AP-1 pathways play an important role in\ninammation related signaling pathways, and these two pathways are downstream of STING\n(Supplemental gure).\nExpression of STING in endometriosis\nWB results showed that the expression of STING signicantly decreased in eutopic endometrium with\nendometriosis compared to the controls (Fig. 1-A). By IHC images (Fig. 1-B), we analyzed eutopic\nendometrium, ectopic endometrium with endometriosis and normal control endometrium, found that\nSTING was expressed in stroma and glandular epithelium of normal control endometrium, but in eutopic\nendometrium with endometriosis, STING was signicantly decreased compared to control endometrium,\n\nPage 6/14\nand mainly expressed in stroma in eutopic endometrium however epithelial tissue in ectopic\nendometrium.\nSTING was essential for HESC function\nAs we found that STING expressed decreased in eutopic endometrium with endometriosis and mainly in\nstroma, we used HESC knockdown STING to explore inuence of STING on HESC function, in order to\nverify STING function on endometriosis. When HESC knockdown STING (transfected with si-STING), EdU\nassay manifested that HESC proliferation was increased signicantly compared to NC (transfected with\nnegative control), si-STING HESC compared to NC group was 0.2866 ± 0.01470 vs. 0.6911 ± 0.01796,\n****P < 0.0001 (Fig. 2-A); Transwell assay showed that HESC invasion(130.0 ± 6.296 vs. 424.1 ± 22.31,\n****P < 0.0001) and migration(82.93 ± 6.940 vs. 82.93 ± 6.940, ****P < 0.0001) were increased signicantly\nafter STING knockdown compared to NC (Fig. 2-B).\nSTING/IRF3/IFNb1 pathway in HESC\nTo explore that how did STING play an important role in HESC, we knockdown STING and study the\nprotein levels of downstream IRF3, pho-IRF3, TBK1, pho-TBK1 and IFNb1, those are STING pathway\nproteins. Western blot results showed that pho-IRF3 and pho-TBK1 were decreased in STING knockdown\ngroup compare to controls, leaded to IFNb1 decreased nally, whish showed in Elisa assay(Fig. 3-B). We\naimed at that how did IFNb1 inuence HESC function, then we added exogenous IFNb1 in HESC with\nknockdown STING (siSTING) and NC, found that invasion and migration of HESC were decreased\nreversely, HESC invasion (IFNb1-NC and IFNb1-siSTING 274.7 ± 7.767 vs. 135.7 ± 12.63, ***P < 0.0001) and\nmigration (IFNb1-NC and IFNb1-siSTING 28.53 ± 3.625 vs. 28.53 ± 3.625, ***P < 0.0001) decreased in\nsiSTING with IFNb1 compared to siSTING, but could not completely reverse the invasion (siSTING and\nIFNb-siSTING 222.9 ± 10.16 vs. 124.1 ± 11.77, ***P < 0.0001) and migration (siSTING and IFNb-siSTING\n49.13 ± 4.241 vs. 135.7 ± 12.63, ****P < 0.0001). However exogenous IFNb1 in HESC with knockdown\nSTING showed no inuence on HESC proliferation, cells proliferation was not decreased in siSTING with\nIFNb1 compared to siSTING (siSTING and IFNb-siSTING 0.6874 ± 0.02081, 0.7187 ± 0.02638, P = 0.795)\n(Fig. 3-C,D).\nDiscussion\nIn this study, we started with proteomic sequencing of endometriosis eutopic endometrium and normal\nendometrium, and found that signicant difference of proteins related to immune factors in\nendometriosis group. According to further analysis, we focused on innate immune protein STING. By\nverifying expression of STING in endometriosis eutopic endometrium, we found that STING was\nexpressed lower in endometriosis compared to controls. The expression of STING in eutopic\nendometrium is mainly in the endometrial stroma, and the decreased of STING lead to increase the\nproliferation, invasion and migration of endometrial stromal cells. Further study of STING protein\nsignaling pathway showed that the phosphorylation of STING/IRF3/IFNb1 also decreased in the HESC\n\nPage 7/14\nwhen STING expression was knockdown, which means that STING signaling pathway was inhibited. By\nexogenous adding IFNb1, the invasion and migration of stromal cells were reversely decreased, which\nindicated that STING signaling pathway affected the function of endometrial stromal cells.\nAt present, it is believed that environment will also affect the molecular structure and function of\nendometriosis endometrium, which resulted in formation of ectopic lesions, and the imbalance of the\nimmune environment of endometriosis is an important reason for the formation of ectopic lesions. The\nimbalances of peripheral circulating immune system and female intrauterine endometrium autoimmunity,\nthose can lead to the occurrence of ectopic lessions of endometriosis, which is associated with infertility,\nearly abortion and abnormal histometaplasia[4, 14, 15]. One transcriptome analysis of endometrium with\nendometriosis found that signaling pathways including lymphocyte activation, antigen presentation,\ncytokine induction and inammation were up-regulated, those were related to the changes of steroid\nhormone expression. This result was similar to our proteomic analysis[16, 17]. We found that signaling\npathways related to immune factors were changed in eutopic endometrium with endometriosis. Gene\nanalysis of endometrium tissue of endometriosis showed that the immune and inammatory factors of\nprogesterone decidualization were important factors affecting endometriosis endometrial receptivity and\nmaintaining pregnancy[18]. Although it is not clear that the cellular components of endometrial tissue are\ncauses of pro-inammatory and pro-immune, still need more researches to conrmed, especially,\nimmuned cells migrated and brotic cells of endometrial matrix in eutopic endometrium[14, 19, 20]. In\nconclusion, recent studies have shown that environment of pro-inammatory in endometriosis is an\nimportant reason for the formation of ectopic lesions, and the environment is closely related to the\npathogenesis of endometriosis and inuence on pregnancy outcomes[15].\nAmong many immune factors, the imbalance of innate immunity of endometriosis is an important reason\nfor the occurrence and development of the disease. STING is an important molecular protein related to\ninnate immunity. As a DNA receptor, it can recognize cellular DNA released. Endogenous molecules\nreleased by endometriosis due to tissue damage or inammatory effect, such as HMGB1 and IL-33, can\nactivate this signaling pathway[21, 22]. The innate immune system can recognize many invaded\npathogens. As a cytokine released by recognizing these microbial molecules, type I interferon plays an\nimportant role in eliminating pathogens. The release of type I interferon mainly depends on TBK1 and\ndownstream transcription regulator IRF3. In addition, transmembrane protein STING is an important\ncellular DNA receptor, which can recognize intracellular DNA then activate TBK1 / IRF3 signaling pathway\nreleased type I interferon. In our study, the expression of STING in eutopic endometrial tissue of\nendometriosis, which called a \"benign cancer\", was decreased, but the proliferation, invasion and\nmigration of endometrial stromal cells increased. These made us suspect that STING may have the same\nanti-tumor effect in endometriosis, which can be used to prevent ectopic lesions formation, and we found\nits signal transduction pathway in endometrial stromal cells had changed. Moreover, exogenous IFNB1\nreduced the invasion and migration of stromal cells, which also showed that STING may play the same\nrole in tumor immunotherapy, and provide new ideas for treatments of endometriosis.\n\nPage 8/14\nThe advantages of our study, rstly, we found that the expression of STING was decreased compared\nwith controls, and mainly expressed in eutopic endometrial stroma of endometriosis, yet expressed in\nglandular epithelium of ectopic endometrium. Secondly, we rst showed that STING had effects on\nfunction of endometrial stromal cells, and its low expression promoted the invasion and migration of\nstromal cells. Thirdly, we rst explained that STING–IRF-IFNb1 signaling pathway played roles in\nendometrial stromal cells; However, our research still has some shortcomings. First, STING, as an\nendoplasmic reticulum anchoring protein, can recognize DNA released and act as a DNA receptor.\nTherefore, we need to study the relationship between STING and endoplasmic reticulum stress, DNA\ndamage repair, and the impact of these relationships on the occurrence and development of\nendometriosis. Second, the experiments in this chapter were in vitro experiments, which still need to be in\nvivo experiments, in order to carry out the verication and deeper mechanism research.\nIn conclusion, STING expressed lower in eutopic endometrial tissue of endometriosis, and mainly\nexpressed in stroma. Its low expression promoted the invasion and migration of endometrial stromal\ncells. STING/IRF3/IFNb1 signaling pathway plays an important role in endometrial stromal cells. The\naddition of exogenous IFNB1 can reversely reduce the invasion and migration of stromal cells, which may\nbe explained the pathogenesis mechanism of endometriosis and provided new ideas of treatment\nmethods.\nConclusion\nIn eutopic endometrium of endometriosis, STING expression was decreased and mainly in the stroma.\nLow expression of STING can promote the invasion and migration of endometrial stromal cells. It is\nfurther found that of STING/IRF3/IFNb1 signaling pathway in functions of HESC, and the addition of\nexogenous IFNB1 can reverse and reduce the invasion and migration of stromal cells.\nAbbreviations\nSTING: stimulator of interferon genes; WB: western blot assay; HESC: human endometrial stromal cell;\nIHC: Immunohistochemistry\nDeclarations\nEthics approval and consent to participate\nThis research was approved by the Ethics Committee of the Reproductive Hospital Aliated to Shandong\nUniversity. Written informed consent was obtained from all participants before study enrollment.\nConsent for publication\nAll authors have consented to the publication of this article. \n\nPage 9/14\nAvailability of supporting data\nAll data generated through this study are included in this article\nCompeting interests\nThe authors declare no potential conicts of interest with respect to the research, authorship, and/or\npublication of this article.\nFunding \nNational Natural Science Foundation of China (82071617)\nAuthors’ contributions\nZX drafted the manuscript and revised it critically for important intellectual content. ZX, HZ, CY, LZ, ML\nand YW contributed to the conception and design of the work or the acquisition, analysis and\ninterpretation of the data. LY approved of nal the version to be published, and agree to be accountable\nfor all aspects of the work in ensuring that\nquestions related to the accuracy or integrity of any part of the work are appropriately investigated and\nresolved.\nAcknowledgements\nWe would like to thank all the endometriosis patients for their participation during this study.\nReferences\n1. Zondervan, K.T., et al., Endometriosis. Nat Rev Dis Primers, 2018.\n2. Shigesi, N., et al., The association between endometriosis and autoimmune diseases: a systematic\nreview and meta-analysis. Human Reproduction Update, 2019. 25(4): p. 486-503.\n3. Vallvé-Juanico, J., S. Houshdaran, and L.C. Giudice, The endometrial immune environment of women\nwith endometriosis. Human Reproduction Update, 2019. 25(5): p. 565-592.\n4. Patel, B.G., et al., Pathogenesis of endometriosis: Interaction between Endocrine and inammatory\npathways. Best Pract Res Clin Obstet Gynaecol, 2018.\n5. Yi, K.W., et al., Endometriosis Is Associated with Adverse Pregnancy Outcomes: a National\nPopulation-Based Study. Reprod Sci, 2020.\n. Akira, S., S. Uematsu, and O. Takeuchi, Pathogen recognition and innate immunity. Cell, 2006.\n7. Yao, Z., et al., Deciphering biomarkers of endometriosis by proteomic analysis of eutopic\nendometrium in infertile patients. J Gynecol Obstet Hum Reprod, 2020.\n\nPage 10/14\n. Burdette, D.L., et al., STING is a direct innate immune sensor of cyclic di-GMP. Nature, 2011.\n478(7370): p. 515-518.\n9. Le Naour, J., et al., Trial watch: STING agonists in cancer therapy. OncoImmunology, 2020. 9(1): p.\n1777624.\n10. Tlemsani, C., et al., SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and\nPharmacology Based on Genomic Signatures. Cell Rep, 2020.\n11. Xu, N., et al., STING agonist promotes CAR T cell tracking and persistence in breast cancer. J Exp\nMed, 2021.\n12. Zhang, Y., et al., β -arrestin 2 as an activator of cGAS-STING signaling and target of viral immune\nevasion. Nat Commun, 2020.\n13. Qu, H., et al., Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression.\nReprod Sci, 2020.\n14. Lessey, B.A., The pathologists are free to go, or are they? Fertil Steril, 2013.\n15. Saraswat, L., et al., Pregnancy outcomes in women with endometriosis: a national record linkage\nstudy. BJOG, 2017.\n1. Houshdaran, S., et al., Aberrant Endometrial DNA Methylome and Associated Gene Expression in\nWomen with Endometriosis. Biol Reprod, 2016.\n17. Tamaresis, J.S., et al., Molecular classication of endometriosis and disease stage using high-\ndimensional genomic data. Endocrinology, 2014.\n1. Ahn, S.H., et al., Immune-inammation gene signatures in endometriosis patients. Fertil Steril, 2016.\n19. Aghajanova, L., M.C. Velarde, and L.C. Giudice, Altered gene expression proling in endometrium:\nevidence for progesterone resistance. Semin Reprod Med, 2010.\n20. Bruner-Tran, K.L., et al., Medical management of endometriosis: emerging evidence linking\ninammation to disease pathophysiology. Minerva Ginecol, 2013.\n21. Zachariah, R., et al., Circulating cell-free DNA as a potential biomarker for minimal and mild\nendometriosis. Reproductive Biomedicine Online, 2009. 18(3): p. 407-411.\n22. Traver, S., et al., Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian,\nendometrial and obstetric disorders and fetal aneuploidy. Human Reproduction Update, 2014(6): p.\n905.\nFigures\n\nPage 11/14\nFigure 1\nThe expression of STING in eutopic endometrium of endometriosis (A) WB results showed that the\nexpression of STING in eutopic endometrium of endometriosis was decreased compared to the controls,\n(B) IHC results showed that STING was signicantly expressed in the stroma and glandular epithelium in\ncontrol endometrium. The expression of STING was mainly in the stroma of eutopic endometrium of\nendometriosis was decreased, but expressed in glandular epithelium of ectopic endometrium. Each\nexperiment was repeated three times\n\nPage 12/14\nFigure 2\nEffect of STING on the function of human endometrial stromal cells (HESC) (A) Edu results showed that\nlow expression of STING can promote the proliferation level. According to EdU positive cells rate, STING\nknockdown (siSTING) in HESC compared to NC group 0.2866 ± 0.01470 vs. 0.6911 ± 0.01796,\n****P<0.0001. (B) And Transwell results showed that low expression of sting could promote the invasion\n(130.0 ± 6.296 vs. 424.1 ± 22.31, ****P<0.0001) and migration (82.93 ± 6.940 vs. 82.93 ± 6.940,\n****P<0.0001) of HESC when knocked down STING. Each experiment was repeated three times\n\nPage 13/14\nFigure 3\nSTING/IRF3/IFNb1 signaling pathway in HESC (A) knocked down STING (si-STING) in HESC cells, WB\nresults showed that STING expression was signicantly decreased. (B) and (C) WB results showed that\nexpressions of phosphorylated IRF3 and TBK1 with knockdown STING were lower than that of total\nprotein IRF3 and tbk1 in STING/IRF3/IFNb1 pathway in HESC. ELISA results showed that the expression\nof IFNb1 with knockdown STING was lower than NC group (*P<0.05). (D) and (E) Transwell results\n\nPage 14/14\nshowed that exogenous IFNB1 could reduce the invasion (IFNb1-NC and IFNb1-siSTING 274.7 ± 7.767 vs.\n135.7 ± 12.63, ***P <0.0001) and migration (IFNb1-NC and IFNb1-siSTING 28.53 ± 3.625 vs. 28.53 ±\n3.625, ***P <0.0001) of HESC with knockdown STING, but could not completely reverse the invasion\n(siSTING and IFNb-siSTING 222.9 ± 10.16 vs. 124.1 ± 11.77, ***P <0.0001) and migration (siSTING and\nIFNb-siSTING 49.13 ± 4.241 vs. 135.7 ± 12.63, ****P<0.0001). EdU results showed that exogenous added\nIFNB1 did not decrease the proliferation of HESC with knockdown STING (siSTING and IFNb-siSTING\n0.6874 ± 0.02081, 0.7187 ± 0.02638, P = 0.795). Each experiment was repeated three times\nSupplementary Files\nThis is a list of supplementary les associated with this preprint. Click to download.\noatimage1.png","source_license":"CC0","license_restricted":false}